KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces an applied research program to evaluate certain molecular characteristics of DehydraTECH processed… Read More
Nominate a researcher who has advanced diversity and equity in Canada by August 1,2024 OTTAWA, ON – The Health Research Foundation (HRF) of Innovative Medicines Canada is calling for nominations for… Read More
TORONTO, ON – PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives… Read More
WELL and HEALWELL AI have launched the second-generation of WELL AI Decision Support (“WAIDS”), which now features advanced chronic disease screening for diseases like chronic kidney disease, hypertension, and diabetes,… Read More
Researchers at the UBC Faculty of Medicine and BC Cancer have developed a new artificial intelligence (AI) model that can accurately predict if a person receiving cancer care will require… Read More
